Skip to menu Skip to content Skip to footer

2006

Other Outputs

Small molecule glycosaminoglycan mimetics

Banwell, M. G., Bonnet, M., Ferro, V., Kreipl, A., Renner, J. and Offermann, D. A. (2006). Small molecule glycosaminoglycan mimetics. WO/2006/135973.

Small molecule glycosaminoglycan mimetics

2006

Journal Article

Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides

Adams, Y., Freeman, C., Schwartz-Albiez, R., Ferro, V., Parish, C.R. and Andrews, K.T. (2006). Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. Antimicrobial Agents and Chemotherapy, 50 (8), 2850-2852. doi: 10.1128/AAC.00313-06

Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides

2006

Journal Article

Spectroscopic and structural characterization of products arising from the base-promoted benzylation of 3-sulfolene

Bonnet, Muriel, Banwell, Martin G., Willis, Anthony C. and Ferro, Vito (2006). Spectroscopic and structural characterization of products arising from the base-promoted benzylation of 3-sulfolene. Arkivoc, 2006 (x), 35-41. doi: 10.3998/ark.5550190.0007.a05

Spectroscopic and structural characterization of products arising from the base-promoted benzylation of 3-sulfolene

2006

Book Chapter

Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects

Hammond, E., Bytheway, I. and Ferro, V. (2006). Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects. New Developments in Therapeutic Glycomics. (pp. 251-282) edited by Maryse Delehedde and Hugues Lortat-Jacob. Trivandrum, India: Research Signpost.

Heparanase as a Target for Anticancer Therapeutics: New Developments and Future Prospects

2006

Journal Article

Anti-herpes simplex virus activities of two novel disulphated cyclitols

Ekblad, M., Bergström, T., Banwell, M. G., Bonnet, M., Renner, J., Ferro, V. and Trybala, E. (2006). Anti-herpes simplex virus activities of two novel disulphated cyclitols. Antiviral Chemistry and Chemotherapy, 17 (2), 97-106. doi: 10.1177/095632020601700205

Anti-herpes simplex virus activities of two novel disulphated cyclitols

2005

Journal Article

Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid

Pearson, A.G., Kiefel, M.J.., Ferro, V. and von Itzstein, M. (2005). Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid. Carbohydrate Research, 340 (13), 2077-2085. doi: 10.1016/j.carres.2005.06.029

Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid

2005

Other Outputs

Sulfated oligosaccharide derivatives

Ferro, Vito, Fairweather, Jon, Karoli, Tomislav and Liu, Ligong (2005). Sulfated oligosaccharide derivatives. WO/2005/085264.

Sulfated oligosaccharide derivatives

2005

Other Outputs

Glycosaminoglycan (GAG) mimetics

Don, Robert Hugh, Ferro, Vito, Bytheway, Ian, Cochran, Siska, Fairweather, Jon Krueger, Hammond, Edward Timothy, Karoli, Tomislav, Li, Cai Ping and Liu, Ligong (2005). Glycosaminoglycan (GAG) mimetics. WO/2005/061523.

Glycosaminoglycan (GAG) mimetics

2005

Journal Article

The synthesis and biological evaluation of two analogues of the C-riboside showdomycin

Renner, J., Kruszelnicki, I., Adamiak, B., Willis, A.C., Hammond, E., Su, S., Burns, C., Trybala, E., Ferro, V. and Banwell, M.G. (2005). The synthesis and biological evaluation of two analogues of the C-riboside showdomycin. Australian Journal of Chemistry, 58 (2), 86-93. doi: 10.1071/CH04273

The synthesis and biological evaluation of two analogues of the C-riboside showdomycin

2005

Conference Publication

PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.

Gautam, AM, Ferro, V, Wilson, EA, Freeman, C and Parish, C (2005). PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.. AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia Pa, Nov 14-18, 2005. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.

PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.

2005

Journal Article

Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins

Freeman, Craig, Liu, Ligong, Banwell, Martin G., Brown, Kathryn J., Bezos, Anna, Ferro, Vito and Parish, Christopher R. (2005). Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins. Journal of Biological Chemistry, 280 (10), 8842-8849. doi: 10.1074/jbc.M410769200

Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins

2005

Journal Article

Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88)

Karoli, Tomislav, Liu, Ligong, Fairweather, Jon K., Hammond, Edward, Li, Cai Ping, Cochran, Siska, Bergefall, Kicki, Trybala, Edward, Addison, Russell S. and Ferro, Vito (2005). Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). Journal of Medicinal Chemistry, 48 (26), 8229-8236. doi: 10.1021/jm050618p

Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88)

2004

Journal Article

The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448

Fairweather, Jon K., Karoli, Tomislav and Ferro, Vito (2004). The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448. Bioorganic & Medicinal Chemistry, 12 (23), 6063-6075. doi: 10.1016/j.bmc.2004.09.005

The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448

2004

Journal Article

A synthetic heparanase inhibitor reduces proteinuria in passive heymann nephritis

Levidiotis, V., Freeman, C., Punler, M., Martinello, P., Creese, B., Ferro, V., van der Vlag, J., Berden, Jo H.M., Parish, C.R. and Power, D.A. (2004). A synthetic heparanase inhibitor reduces proteinuria in passive heymann nephritis. Journal of the American Society of Nephrology, 15 (11), 2882-2892. doi: 10.1097/01.ASN.0000142426.55612.6D

A synthetic heparanase inhibitor reduces proteinuria in passive heymann nephritis

2004

Journal Article

The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation

Ferro, V., Hammond, E. and Fairweather, J. K. (2004). The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation. Mini Reviews in Medicinal Chemistry, 4 (6), 693-702. doi: 10.2174/1389557043403729

The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation

2004

Journal Article

The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus

Nyberg, K., Ekblad, M., Bergström, T., Freeman, C., Parish, C.R., Ferro, V. and Trybal, E. (2004). The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Research, 63 (1), 15-24. doi: 10.1016/j.antiviral.2004.01.001

The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus

2004

Journal Article

Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries

Liu, L., Li, C.P., Cochran, S. and Ferro, V. (2004). Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries. Bioorganic & Medicinal Chemistry Letters, 14 (9), 2221-2226. doi: 10.1016/j.bmcl.2004.02.017

Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries

2004

Journal Article

The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448.

Fairweather, J.K., Karoli, T. and Ferro, V. (2004). The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448.. Bioorganic & Medicinal Chemistry (12), 6063-6075.

The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448.

2003

Journal Article

Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance

Cochran, S., Li, C., Fairweather, J.K., Kett, W.C., Coombe, D.R. and Ferro, V. (2003). Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance. Journal of Medicinal Chemistry, 46 (21), 4601-4608. doi: 10.1021/jm030180y

Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance

2003

Journal Article

The development of the novel angiogenesis inhibitor PI-88 as an anticancer drug

Ferro, V. and Don, R. (2003). The development of the novel angiogenesis inhibitor PI-88 as an anticancer drug. Australasian Biotechnology, 13 (1), 38-39.

The development of the novel angiogenesis inhibitor PI-88 as an anticancer drug